Nanotechnology Now

Our NanoNews Digest Sponsors


Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > Medtech Insight and Windhover Information Announce Their Upcoming ``Investment In Innovation (In3) Europe'' Early- to Late-Stage Medical Technology In

Abstract:
April 29-30, 2008, Paris, France, The Hilton Paris

Medtech Insight and Windhover Information Announce Their Upcoming ``Investment In Innovation (In3) Europe'' Early- to Late-Stage Medical Technology In

NEWPORT BEACH, CA | Posted on January 16th, 2008

Medtech Insight, a division of Windhover Information, Inc. and a leading provider of business information for the medical device industry, will host the upcoming "Investment In Innovation (In3) Europe" conference April 29-30, 2008 at The Hilton Paris Hotel in Paris, France. In3 Europe - the company's 30th In3 conference - will showcase over 30 highly promising start-up med device companies from around the world presenting to an audience of senior business development and investment executives from the leading medical technology and healthcare investment firms worldwide, for purposes of raising funding or forming strategic partnerships. Event details will be posted regularly on the In3 Europe website, at www.windhover.com/in3europe08.

Presentations from a carefully selected group of cutting-edge, early- to late-stage companies will encompass a wide variety of high-growth device sectors, including cardiovascular therapeutics and diagnostics/interventional cardiology, diagnostics, drug delivery, imaging, minimally invasive surgery, nanotechnology, neurostimulation, oncology, orthopedics/spine, peripheral vascular, stem cells, stroke management, tissue engineering, and wound management, to mention only a few.

The In3 Europe format will include focused 10-minute presentations by a senior executive from each presenting company to our full audience, each followed immediately by one-on-one meetings with interested parties in private breakout rooms. The event will also feature plenary sessions by device industry thought leaders, informative and interactive panel discussions covering a variety of topics impacting medical device innovation and investment in the U.S., Europe, and other regions, a presenting company product exhibition/networking reception, and educational workshops.

Medtech Insight and its parent company, Windhover Information, have established a reputation as holding the premier forums worldwide for discerning senior executives in the medical device, diagnostics, biotech, and pharmaceutical business development and investment communities to meet and screen promising early-stage life sciences companies in need of funding, acquisition and/or strategic partnership, and to network with key decision makers in the industry. Over 1350 emerging medical technology company presenters and over 7200 attendees have participated at In3 events over the past 7 years.

In3 Europe is a must-attend event for anyone interested in emerging medical technology impacting the worldwide med device market. To register to attend, or if your company is interested in presenting, call Kristy Grimes of Medtech Insight at 480-985-9512, 888-202-5939 toll-free in the U.S., or register on the Medtech Insight website at www.windhover.com/in3europe08. The early bird attendee registration rate of $1295 ($400 off the regular rate) expires February 16, 2008.

Medtech Insight and Windhover Information will also be holding their "Investment In Innovation (In3) Summit" conference in San Francisco, CA, June 17-19, featuring over 50 medtech company presentations in 3 concurrent specialty tracks, as well as their "In3 East" conference in Boston, MA, October 22-24. For more information on these upcoming events, please call Medtech Insight or visit the company's website at www.medtechinsight.com.

####

About Medtech Insight
Medtech Insight, a division of Windhover Information Inc., is the leading provider of business information and market intelligence for the medical technology marketplace.

For more information, please click here

Contacts:
Medtech Insight, a division of Windhover Information Inc.
Kristy Grimes
480-985-9512
or 888-202-5939 toll-free in the U.S.

www.medtechinsight.com
www.windhover.com

Copyright © Business Wire 2008

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Simple attraction: Researchers control protein release from nanoparticles without encapsulation: U of T Engineering discovery stands to improve reliability and fabrication process for treatments to conditions such as spinal cord damage and stroke May 28th, 2016

Scientists illuminate a hidden regulator in gene transcription: New super-resolution technique visualizes important role of short-lived enzyme clusters May 27th, 2016

Doubling down on Schrödinger's cat May 27th, 2016

Deep Space Industries and SFL selected to provide satellites for HawkEye 360’s Pathfinder mission: The privately-funded space-based global wireless signal monitoring system will be developed by Deep Space Industries and UTIAS Space Flight Laboratory May 26th, 2016

Investments/IPO's/Splits

Nanometrics Announces Upcoming Investor Events May 10th, 2016

ORIG3N Added to Companies Presenting at Harris & Harris Group's Annual Meeting, Tuesday June 7, 2016, the New York Genome Center April 27th, 2016

Aspen Aerogels to Present at the 28th Annual ROTH Conference March 14th, 2016

Harris & Harris Group Announces Formation of Co-Investment Fund for Accredited Investors March 9th, 2016

Nanomedicine

Simple attraction: Researchers control protein release from nanoparticles without encapsulation: U of T Engineering discovery stands to improve reliability and fabrication process for treatments to conditions such as spinal cord damage and stroke May 28th, 2016

Scientists illuminate a hidden regulator in gene transcription: New super-resolution technique visualizes important role of short-lived enzyme clusters May 27th, 2016

Supercrystals with new architecture can enhance drug synthesis May 24th, 2016

Nanoscale Trojan horses treat inflammation May 24th, 2016

Announcements

Simple attraction: Researchers control protein release from nanoparticles without encapsulation: U of T Engineering discovery stands to improve reliability and fabrication process for treatments to conditions such as spinal cord damage and stroke May 28th, 2016

Scientists illuminate a hidden regulator in gene transcription: New super-resolution technique visualizes important role of short-lived enzyme clusters May 27th, 2016

Doubling down on Schrödinger's cat May 27th, 2016

Deep Space Industries and SFL selected to provide satellites for HawkEye 360’s Pathfinder mission: The privately-funded space-based global wireless signal monitoring system will be developed by Deep Space Industries and UTIAS Space Flight Laboratory May 26th, 2016

Events/Classes

Novel gene therapy shows potential for lung repair in asthma May 18th, 2016

Arrowhead Pharmaceuticals' Preclinical Candidate ARC-LPA Achieves 98% Knockdown and Long Duration of Effect after Subcutaneous Administration May 10th, 2016

Nanometrics Announces Upcoming Investor Events May 10th, 2016

Oxford Instruments Asylum Research and McGill University Announce the McGill AFM Summer School and Workshop, May 12-13, 2016 May 4th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic